Bryhali Lotion
Product Images NDC 0187-0002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bryhali (NDC 0187-0002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description.jpg (Description)

FDA Label Image

Figure1 (Image 01)

Figure1 (Image 01)
This appears to be a table presenting the result of two trials for a product named BRYHALI. The table shows the percentage of subjects with successful treatment for each trial, along with a comparison to treatment with a vehicle (likely a placebo) and no treatment at a 4 week follow-up. There is not enough information to determine what condition or ailment the product is designed to treat.*
FDA Label Image

Image 02

Image 02
This is a description of a medication lotion named "wBRYHALL" with the active ingredient "halobetasol propionate". The lotion is intended for topical use only. The net weight of the lotion is 100g. The label includes product and manufacturing information such as dosage recommendation, distribution company, patent numbers, and manufacturer name.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.